PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Tilray Brands, Inc. (TLRY.TO)
2.000.05 (2.56%)
1.90 - 2.15
0.48 - 2.54
9.88M / 3.06M (Avg.)
-0.59 | -3.40
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
2.18%
Revenue growth under 50% of OGI.TO's 13.20%. Michael Burry would suspect a deteriorating sales pipeline or weaker brand.
-22.45%
Negative gross profit growth while OGI.TO is at 42.74%. Joel Greenblatt would examine cost competitiveness or demand decline.
-866.94%
Negative EBIT growth while OGI.TO is at 57.38%. Joel Greenblatt would demand a turnaround plan focusing on core profitability.
-866.94%
Negative operating income growth while OGI.TO is at 57.38%. Joel Greenblatt would press for urgent turnaround measures.
-1775.75%
Negative net income growth while OGI.TO stands at 57.06%. Joel Greenblatt would push for a reevaluation of cost or revenue strategies.
-1785.39%
Negative EPS growth while OGI.TO is at 60.98%. Joel Greenblatt would expect urgent managerial action on costs or revenue drivers.
-1785.39%
Negative diluted EPS growth while OGI.TO is at 61.27%. Joel Greenblatt would require immediate efforts to restrain share issuance or boost net income.
11.26%
Share count expansion well above OGI.TO's 10.25%. Michael Burry would question if management is raising capital unnecessarily or is over-incentivizing employees with stock.
11.07%
Diluted share count expanding well above OGI.TO's 10.38%. Michael Burry would fear significant dilution to existing owners' stakes.
No Data
No Data available this quarter, please select a different quarter.
90.83%
Positive OCF growth while OGI.TO is negative. John Neff would see this as a clear operational advantage vs. the competitor.
68.66%
Positive FCF growth while OGI.TO is negative. John Neff would see a strong competitive edge in net cash generation.
No Data
No Data available this quarter, please select a different quarter.
4893.26%
5Y revenue/share CAGR above 1.5x OGI.TO's 3219.14%. David Dodd would look for consistent product or market expansions fueling outperformance.
1224.22%
3Y revenue/share CAGR at 50-75% of OGI.TO's 1959.40%. Martin Whitman would question if the firm lags behind competitor innovations.
-1227.10%
Both show negative 10Y OCF/share CAGR. Martin Whitman would question if the entire market or product set is shrinking or too capital-intensive.
15.30%
Positive OCF/share growth while OGI.TO is negative. John Neff might see a comparative advantage in operational cash viability.
-7393.93%
Both face negative short-term OCF/share growth. Martin Whitman would suspect macro or cyclical issues hitting them both.
-5688.60%
Both face negative decade-long net income/share CAGR. Martin Whitman would suspect a shrinking or highly disrupted sector.
-3007.60%
Both exhibit negative net income/share growth over five years. Martin Whitman would suspect a challenging environment for the entire niche.
-1597.85%
Both companies show negative 3Y net income/share growth. Martin Whitman suspects macro or sector-specific headwinds in the short run.
5422.95%
Equity/share CAGR of 5422.95% while OGI.TO is zero. Bruce Berkowitz might see a slight advantage that can compound significantly over 10 years.
2128.90%
5Y equity/share CAGR at 50-75% of OGI.TO's 4091.58%. Martin Whitman would question a shortfall in capital accumulation vs. the competitor.
211.19%
Below 50% of OGI.TO's 681.77%. Michael Burry suspects a serious short-term disadvantage in building book value.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-37.46%
Firm’s AR is declining while OGI.TO shows 31.22%. Joel Greenblatt sees stronger working capital efficiency if sales hold up.
13.05%
We show growth while OGI.TO is shrinking stock. John Neff wonders if the competitor is more disciplined or has weaker demand expectations.
-7.26%
Both reduce assets yoy. Martin Whitman suspects a broader sector retraction or post-boom asset trimming cycle.
-14.39%
Both erode book value/share. Martin Whitman suspects a difficult environment or poor capital deployment for both players.
-17.06%
We’re deleveraging while OGI.TO stands at 17.55%. Joel Greenblatt considers if we gain a balance-sheet advantage for potential downturns.
-21.64%
Our R&D shrinks while OGI.TO invests at 114.45%. Joel Greenblatt checks if we risk falling behind a competitor’s new product pipeline.
2.01%
SG&A growth well above OGI.TO's 0.54%. Michael Burry sees potential margin erosion unless it translates into higher sales or brand equity.